We answer three questions rapidly: Where is it? How large? How aggressive? Our pathway delivers answers within days:
The gold standard. Dural-based, homogeneously enhancing mass with a "dural tail" sign. Also reveals edema and mass effect on surrounding brain.
Evaluates hyperostosis (bone thickening) and skull-base involvement—critical for surgical planning.
If surgery or biopsy is performed, WHO grading (I–III) determines surveillance intensity and adjuvant therapy need.
